Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857150 · ClinicalTrials.gov registry record
Exercise Response in Humans With Obesity
A clinical trial of Obese, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT05857150 is a study of Obese that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, below the 207-participant average among 27 other Obese trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05857150, a study of Obese, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to understand how chronic inflammation affects muscle function and responses to exercise.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Strength Test
- PROCEDURE Muscle Biopsy
- DIAGNOSTIC_TEST Treadmill Test
- DIAGNOSTIC_TEST Dual-Energy X-Ray Absorptiometry
- PROCEDURE Fat Biopsy
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-09-22 |
| Est. Completion | 2029-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05857150
The ClinicalTrials.gov registry entry for NCT05857150 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 27 other Obese trials with a reported enrollment target (42% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obese appearing as the primary indexed condition, and to 5 interventions - of which Strength Test is the first listed.
NCT05857150 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05857150 about?
NCT05857150 is a clinical study titled "Exercise Response in Humans With Obesity". This study is being done to understand how chronic inflammation affects muscle function and responses to exercise.
What is the current status of trial NCT05857150?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2023-09-22. Estimated completion is 2029-07.
What conditions does trial NCT05857150 study?
This clinical trial studies the following conditions: Obese.
What interventions are being tested in trial NCT05857150?
The interventions under investigation include: Strength Test (DIAGNOSTIC_TEST), Muscle Biopsy (PROCEDURE), Treadmill Test (DIAGNOSTIC_TEST), Dual-Energy X-Ray Absorptiometry (DIAGNOSTIC_TEST), Fat Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05857150?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05857150 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obese
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
RECRUITING · Phase 2
-
A Single Ascending Dose Study of HM17321 in Healthy Adult Participants
RECRUITING · Phase 1
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)
RECRUITING · Phase 2
-
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.